Advertisement
Research Article

Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease

  • Carol Man Gao equal contributor,

    equal contributor Contributed equally to this work with: Carol Man Gao, Alice Y. Yam

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    X
  • Alice Y. Yam equal contributor,

    equal contributor Contributed equally to this work with: Carol Man Gao, Alice Y. Yam

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    X
  • Xuemei Wang,

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    X
  • Erika Magdangal,

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    X
  • Cleo Salisbury,

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    X
  • David Peretz,

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    X
  • Ronald N. Zuckermann,

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    Current address: Lawrence Berkeley National Laboratory, Molecular Foundry, Berkeley, California, United States of America

    X
  • Michael D. Connolly,

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    Current address: Lawrence Berkeley National Laboratory, Molecular Foundry, Berkeley, California, United States of America

    X
  • Oskar Hansson,

    Affiliation: Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden

    X
  • Lennart Minthon,

    Affiliation: Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden

    X
  • Henrik Zetterberg,

    Affiliation: Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden

    X
  • Kaj Blennow,

    Affiliation: Clinical Neurochemistry Laboratory, Department of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden

    X
  • Joseph P. Fedynyshyn mail,

    joseph.fedynyshyn@novartis.com

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    X
  • Sophie Allauzen

    Affiliation: Research and Development, Novartis Vaccines and Diagnostics, Emeryville, California, United States of America

    X
  • Published: December 30, 2010
  • DOI: 10.1371/journal.pone.0015725

Reader Comments (0)

Post a new comment on this article